🇺🇸 FDA
Patent

US 9051319

Inhibitors of influenza viruses replication

granted A61KA61K31/215A61K31/351

Quick answer

US patent 9051319 (Inhibitors of influenza viruses replication) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/215, A61K31/351, A61K31/444, A61K31/497